Maravai LifeSciences Holdings Yönetim
Yönetim kriter kontrolleri 4/4
Maravai LifeSciences Holdings CEO'su Trey Martin, Jul2023 tarihinde atandı, in görev süresi 1.33 yıldır. in toplam yıllık tazminatı $ 2.30M olup, şirket hissesi ve opsiyonları dahil olmak üzere 32.6% maaş ve 67.4% ikramiyelerden oluşmaktadır. şirketin hisselerinin 0.11% ine doğrudan sahiptir ve bu hisseler $ 1.33M değerindedir. Yönetim ekibinin ve yönetim kurulunun ortalama görev süresi sırasıyla 2.4 yıl ve 4 yıldır.
Anahtar bilgiler
Trey Martin
İcra Kurulu Başkanı
US$2.3m
Toplam tazminat
| CEO maaş yüzdesi | 32.6% |
| CEO görev süresi | 1.3yrs |
| CEO sahipliği | 0.1% |
| Yönetim ortalama görev süresi | 2.4yrs |
| Yönetim Kurulu ortalama görev süresi | 4yrs |
Son yönetim güncellemeleri
Recent updates
Slammed 37% Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Screens Well Here But There Might Be A Catch
Nov 11
Does Maravai LifeSciences Holdings (NASDAQ:MRVI) Have A Healthy Balance Sheet?
Oct 15Maravai LifeSciences Holdings, Inc.'s (NASDAQ:MRVI) 29% Jump Shows Its Popularity With Investors
Jul 18Does Maravai LifeSciences Holdings (NASDAQ:MRVI) Have A Healthy Balance Sheet?
Jul 15Maravai: Embedded Expectations Remain Too High Considering Economic Calculus
Jul 12RGA Investment Advisors - Maravai: Two Elite Assets With Other-Worldly Margins Wrapped In One
Jun 12Revenues Tell The Story For Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) As Its Stock Soars 25%
May 14An Intrinsic Calculation For Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Suggests It's 23% Undervalued
Apr 07Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Stocks Shoot Up 28% But Its P/S Still Looks Reasonable
Feb 28Revenues Working Against Maravai LifeSciences Holdings, Inc.'s (NASDAQ:MRVI) Share Price
Dec 19Need To Know: Analysts Just Made A Substantial Cut To Their Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Estimates
Aug 14Are Investors Undervaluing Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) By 27%?
Feb 28Is Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Expensive For A Reason? A Look At Its Intrinsic Value
Nov 01Maravai Lifesciences temporarily reinstates Carl Hull as CEO
Oct 19Maravai LifeSciences appoints former Danaher executive as CEO
Oct 03Maravai LifeSciences Holdings GAAP EPS of $0.53 beats by $0.15, revenue of $242.73M beats by $9.51M
Aug 04Estimating The Intrinsic Value Of Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI)
Jun 27Maravai LifeSciences Holdings, Inc.'s (NASDAQ:MRVI) Intrinsic Value Is Potentially 25% Below Its Share Price
Mar 29CEO Tazminat Analizi
| Tarih | Toplam Tazminat | Maaş | Şirket Kazançları |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | -US$225m |
| Jun 30 2024 | n/a | n/a | -US$132m |
| Mar 31 2024 | n/a | n/a | -US$131m |
| Dec 31 2023 | US$2m | US$750k | -US$119m |
| Sep 30 2023 | n/a | n/a | US$25m |
| Jun 30 2023 | n/a | n/a | US$75m |
| Mar 31 2023 | n/a | n/a | US$153m |
| Dec 31 2022 | US$15m | US$660k | US$220m |
Tazminat ve Piyasa: Trey 'nin toplam tazminatı ($USD 2.30M ), US pazarındaki benzer büyüklükteki şirketler için ortalamanın altındadır ($USD 5.37M ).
Tazminat ve Kazançlar: Trey 'in tazminatı, şirketin son bir yıldaki performansıyla tutarlıydı.
CEO
Trey Martin (49 yo)
1.3yrs
Görev süresi
US$2,301,864
Tazminat
Mr. William E. Martin, III, also known as Trey, is Director of Maravai LifeSciences Holdings, Inc. from July 31, 2024. He was President of Biologics Safety Testing of Maravai LifeSciences Holdings, Inc. si...
Liderlik Ekibi
| İsim | Pozisyon | Görev süresi | Tazminat | Sahiplik |
|---|---|---|---|---|
| Co-Founder & Executive Chairman | 4yrs | US$5.22m | 0.19% $ 2.4m | |
| CEO & Director | 1.3yrs | US$2.30m | 0.11% $ 1.3m | |
| Executive VP & CFO | 7.5yrs | US$2.79m | 0.022% $ 270.2k | |
| Executive VP & Chief Administrative Officer | 2.4yrs | US$2.83m | 0.039% $ 480.5k | |
| Executive VP & GM of Cygnus Technologies | 7.1yrs | US$2.26m | 0.020% $ 239.3k | |
| President of Nucleic Acid Production | 1.7yrs | US$2.99m | 0.024% $ 290.1k | |
| Senior Director of Investor Relations | no data | Veri yok | Veri yok | |
| Executive VP | 4yrs | US$701.40k | 0.018% $ 222.6k | |
| Executive VP & Chief Commercial Officer | 1.8yrs | Veri yok | 0.014% $ 168.8k | |
| Chief Innovation Officer | 1.8yrs | Veri yok | Veri yok |
2.4yrs
Ortalama Görev Süresi
55yo
Ortalama Yaş
Deneyimli Yönetim: MRVI 'un yönetim ekibi deneyimli olarak değerlendirilmektedir (ortalama görev süresi 2.4 yıldır).
Yönetim Kurulu Üyeleri
| İsim | Pozisyon | Görev süresi | Tazminat | Sahiplik |
|---|---|---|---|---|
| Co-Founder & Executive Chairman | 4yrs | US$5.22m | 0.19% $ 2.4m | |
| CEO & Director | less than a year | US$2.30m | 0.11% $ 1.3m | |
| Independent Director | 1.3yrs | US$435.03k | 0.049% $ 601.0k | |
| Non-Independent Director | 4yrs | US$370.48k | 0.0030% $ 36.6k | |
| Non-Independent Director | 4yrs | US$367.98k | 0.0030% $ 36.6k | |
| Independent Director | 4yrs | US$360.48k | 0.022% $ 267.0k | |
| Independent Director | 4yrs | US$395.48k | 0.025% $ 310.0k | |
| Non-Independent Director | 4yrs | US$360.48k | 0.0030% $ 36.6k | |
| Non-Independent Director | 4yrs | US$360.48k | 0.0030% $ 36.6k | |
| Independent Director | 4yrs | US$367.98k | 0.015% $ 178.7k | |
| Independent Director | 4yrs | US$387.98k | 0.047% $ 567.5k |
4.0yrs
Ortalama Görev Süresi
59yo
Ortalama Yaş
Deneyimli Yönetim Kurulu: MRVI 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 4 yıldır).